Zobrazeno 1 - 8
of 8
pro vyhledávání: '"35"'
Publikováno v:
Blood. 110:3526-3531
Patients with severe immune thrombocytopenic purpura (ITP) may require an acute increase in the platelet count for surgery or ongoing hemorrhage as well as long-term maintenance treatment. Certain of these patients may be refractory to steroids, intr
Autor:
Mario Lazzarino, S Torsello, Umberto Bertazzoni, Carlo Bernasconi, Anna Ivana Scovassi, Ercole Brusamolino, Paola Isernia
Publikováno v:
Scopus-Elsevier
We have analyzed the distribution and prognostic significance of terminal deoxynucleotidyl transferase (TdT) and adenosine deaminase (ADA) in connection with conventional cytology, cytogenetics, response to therapy, and survival. The study population
Autor:
Paul Lopes Cardozo, Sergio Amadori, Giovanna Corbelli, Michele Baccarani, Roel Willemze, Sante Tura, Franco Mandelli, Giovanna Meloni, Alice Drenthe-Schonk, Clemens Haanen
Publikováno v:
Scopus-Elsevier
The case histories of 293 adolescent and adult patients with acute lymphoblastic leukemia (ALL) first seen and treated between 1969 and 1979 are reviewed. A complete remission (CR) was achieved in 79% of cases. Male sex, advanced age (greater than or
Autor:
Aloysius Ho, David I. Marks, Ghulam J. Mufti, Judith C. W. Marsh, Vikas Gupta, M. Serajul Islam, Nigel H. Russell, Janet Hayden, Mickey Koh, Antonio Pagliuca, ZiYi Lim, Robin M. Ireland, Victoria Potter
Publikováno v:
Blood. 118:2351-2357
We evaluated a novel alemtuzumab-based conditioning regimen in HSCT for acquired severe aplastic anemia (SAA). In a multicenter retrospective study, 50 patients received transplants from matched sibling donors (MSD; n = 21) and unrelated donors (UD;
Autor:
Tony Williams, Sergio Santillana, Elihu H. Estey, Dan Douer, John M. Bennett, Gabriel Lopez-Bernstein, Kristi A. Boehm
Publikováno v:
Blood. 97:73-80
A novel intravenous liposomal formulation of all-transretinoic acid (ATRA) was evaluated in 69 patients with acute promyelocytic leukemia (APL): 32 new diagnoses, 35 relapses, and 2 oral ATRA failures. Liposomal ATRA (90 mg/m2) was administered every
Autor:
Elena Rossi, Katia Paciaroni, Marco Molinari, Pietro Attilio Tonali, Serenella Servidei, Giuseppe Leone, Valerio De Stefano, I Casorelli, Patrizia Chiusolo
Publikováno v:
Scopus-Elsevier
The factor II G20210A mutation is a recently identified congenital risk factor for venous thrombosis. Its role in artery disease is still undefined. We investigated 72 patients (35 male and 37 female) with documented ischemic stroke occurred before 5
Autor:
Ella Naparstek, Chaim Brautbar, Shimon Slavin, Avraham Amar, Memet Aker, Amiram Eldor, Mark Kirschbaum, Aliza Ackerstein, Yossi Kapelushnik, Ofira Ben-Tal, G. Varadi, Reuven Or, Simcha Samuel, Arnon Nagler, Gabriel Cividalli
Publikováno v:
Blood. 91:756-763
Myeloablative conditioning associated with hazardous immediate and late complications is considered as a mandatory first step in preparation for allogeneic blood or marrow transplantation (allogeneic BMT) for the treatment of malignant hematologic di
Autor:
Martin S. Tallman, Waleska S. Pérez, Mitchell S. Cairo, Corey Cutler, Selina M. Luger, Armand Keating, David I. Marks, J. Douglas Rizzo, Philip L. McCarthy, Jorge Sierra, Gordon L. Phillips, Robert Peter Gale, Marcos de Lima, Hillard M. Lazarus, Daniel J. Weisdorf, Richard T. Maziarz, John F. DiPersio, Marcelo C. Pasquini, Mark R. Litzow, Bruce M. Camitta, Sergey Tarima, Brian J. Bolwell
Publikováno v:
BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Politècnica de Catalunya (UPC)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Politècnica de Catalunya (UPC)
Therapy-related myelodysplastic syndromes (t-MDSs) and acute myeloid leukemia (t-AML) have a poor prognosis with conventional therapy. Encouraging results are reported after allogeneic transplantation. We analyzed outcomes in 868 persons with t-AML (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::930bc619f59356e6391ea3b86f452e2a
https://europepmc.org/articles/PMC2832815/
https://europepmc.org/articles/PMC2832815/